SCHEMBL30485061

SCHEMBL30485061

CNC(=O)C1CN(C(=O)C=CCN(C)C)C1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 8/20 0.37
▸ BTK Q06187 3/20 0.36
▸ CDK7 P50613 2/20 0.35
▸ CDK9 P50750 2/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ CDK14 O94921 1/20 0.35
▸ CCNY Q8ND76 1/20 0.35
▸ FGFR2 P21802 3/20 0.33
▸ FGFR1 P11362 2/20 0.33
▸ CCNK O75909 2/20 0.33
▸ CDK12 Q9NYV4 2/20 0.33
▸ EGFR P00533 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ FGFR4 P22455 1/20 0.33
▸ FGFR3 P22607 1/20 0.33
▸ TXK P42681 1/20 0.33
▸ ITK Q08881 1/20 0.33
▸ CDK4 P11802 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20416389 0.87 CDK2 (0.45) JAK3BTKCDK7CDK9CDK2
SCHEMBL18909668 0.79 CHRNB2 (0.38) JAK3BTKFGFR2FGFR1EGFR
SCHEMBL25977011 0.78 JAK3 (0.37) JAK3BTKCDK7CDK9CDK14
SCHEMBL22631089 0.78 JAK3 (0.37) JAK3BTKFGFR2FGFR1CCNK
SCHEMBL31062632 0.77 CHRNB2 (0.35) JAK3
SCHEMBL18909558 0.76 JAK3 (0.41) JAK3BTKFGFR2FGFR1EGFR
SCHEMBL20839697 0.76 JAK3 (0.41) JAK3BTKCDK7CDK9CDK2
SCHEMBL20839695 0.76 JAK3 (0.41) JAK3BTKCDK7CDK9CDK2
SCHEMBL29774313 0.75 SMN1; SMN2 (0.46) JAK3BTKCDK7CDK9FGFR2
SCHEMBL20892791 0.75 JAK3 (0.36) JAK3BTKCDK7CDK9FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4419207-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER Artios Pharma Limited (GB) 2024-08-28 — — EP disclosed
WO-2023067354-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 — — WO disclosed
Send feedback